ID S22A5_MOUSE Reviewed; 557 AA. AC Q9Z0E8; DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-1999, sequence version 1. DT 27-MAR-2024, entry version 176. DE RecName: Full=Organic cation/carnitine transporter 2; DE AltName: Full=High-affinity sodium-dependent carnitine cotransporter; DE AltName: Full=Solute carrier family 22 member 5; GN Name=Slc22a5 {ECO:0000312|MGI:MGI:1329012}; GN Synonyms=Octn2 {ECO:0000303|PubMed:10454528, GN ECO:0000303|PubMed:9837751}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=C57BL/6J; TISSUE=Kidney; RX PubMed=9916797; DOI=10.1038/5030; RA Nezu J., Tamai I., Oku A., Ohashi R., Yabuuchi H., Hashimoto N., RA Nikaido H., Sai Y., Koizumi A., Shoji Y., Takada G., Matsuishi T., RA Yashino M., Kato H., Ohura T., Tsujimoto G., Hayakawa J., Shimane M., RA Tsuji A.; RT "Primary systemic carnitine deficiency is caused by mutations in a gene RT encoding sodium ion-dependent carnitine transporter."; RL Nat. Genet. 21:91-94(1999). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT JVS ARG-352. RC STRAIN=C3H/HeJ; RX PubMed=9837751; DOI=10.1006/bbrc.1998.9708; RA Lu K., Nishimori H., Nakamura Y., Shima K., Kuwajima M.; RT "A missense mutation of mouse OCTN2, a sodium-dependent carnitine RT cotransporter, in the juvenile visceral steatosis mouse."; RL Biochem. Biophys. Res. Commun. 252:590-594(1998). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TRANSPORTER ACTIVITY. RX PubMed=10454528; RA Wu X., Huang W., Prasad P.D., Seth P., Rajan D.P., Leibach F.H., Chen J., RA Conway S.J., Ganapathy V.; RT "Functional characteristics and tissue distribution pattern of organic RT cation transporter 2 (OCTN2), an organic cation/carnitine transporter."; RL J. Pharmacol. Exp. Ther. 290:1482-1492(1999). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=FVB/N; TISSUE=Colon; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP TISSUE SPECIFICITY. RX PubMed=11010964; DOI=10.1074/jbc.m005340200; RA Tamai I., Ohashi R., Nezu J., Sai Y., Kobayashi D., Oku A., Shimane M., RA Tsuji A.; RT "Molecular and functional characterization of organic cation/carnitine RT transporter family in mice."; RL J. Biol. Chem. 275:40064-40072(2000). RN [6] RP SUBCELLULAR LOCATION, AND INTERACTION WITH PDZK1. RX PubMed=15523054; DOI=10.1124/mol.104.002212; RA Kato Y., Sai Y., Yoshida K., Watanabe C., Hirata T., Tsuji A.; RT "PDZK1 directly regulates the function of organic cation/carnitine RT transporter OCTN2."; RL Mol. Pharmacol. 67:734-743(2005). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-550, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006; RA Trost M., English L., Lemieux S., Courcelles M., Desjardins M., RA Thibault P.; RT "The phagosomal proteome in interferon-gamma-activated macrophages."; RL Immunity 30:143-154(2009). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, and Kidney; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [9] RP FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INDUCTION BY CYTOKINES, RP AND TRANSPORTER ACTIVITY. RX PubMed=20722056; DOI=10.1002/ibd.21444; RA Fujiya M., Inaba Y., Musch M.W., Hu S., Kohgo Y., Chang E.B.; RT "Cytokine regulation of OCTN2 expression and activity in small and large RT intestine."; RL Inflamm. Bowel Dis. 17:907-916(2011). CC -!- FUNCTION: Sodium-ion dependent, high affinity carnitine transporter. CC Involved in the active cellular uptake of carnitine. Transports one CC sodium ion with one molecule of carnitine (PubMed:10454528, CC PubMed:20722056). Also transports organic cations such as CC tetraethylammonium (TEA) without the involvement of sodium. Also CC relative uptake activity ratio of carnitine to TEA is 11.3 CC (PubMed:10454528). May also contribute to regulate the transport of CC organic compounds in testis across the blood-testis-barrier (By CC similarity). {ECO:0000250|UniProtKB:O70594, CC ECO:0000269|PubMed:10454528, ECO:0000269|PubMed:20722056}. CC -!- CATALYTIC ACTIVITY: CC Reaction=(R)-carnitine(out) + Na(+)(out) = (R)-carnitine(in) + CC Na(+)(in); Xref=Rhea:RHEA:72091, ChEBI:CHEBI:16347, CC ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:10454528, CC ECO:0000269|PubMed:20722056}; CC -!- CATALYTIC ACTIVITY: CC Reaction=glycine betaine(out) + Na(+)(out) = glycine betaine(in) + CC Na(+)(in); Xref=Rhea:RHEA:72115, ChEBI:CHEBI:17750, CC ChEBI:CHEBI:29101; Evidence={ECO:0000250|UniProtKB:O76082}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(R)-carnitine(in) + glycine betaine(out) = (R)-carnitine(out) CC + glycine betaine(in); Xref=Rhea:RHEA:72119, ChEBI:CHEBI:16347, CC ChEBI:CHEBI:17750; Evidence={ECO:0000250|UniProtKB:O76082}; CC -!- CATALYTIC ACTIVITY: CC Reaction=Na(+)(out) + O-butanoyl-(R)-carnitine(out) = Na(+)(in) + O- CC butanoyl-(R)-carnitine(in); Xref=Rhea:RHEA:72123, ChEBI:CHEBI:21949, CC ChEBI:CHEBI:29101; Evidence={ECO:0000250|UniProtKB:O76082}; CC -!- CATALYTIC ACTIVITY: CC Reaction=Na(+)(out) + O-acetyl-(R)-carnitine(out) = Na(+)(in) + O- CC acetyl-(R)-carnitine(in); Xref=Rhea:RHEA:72099, ChEBI:CHEBI:29101, CC ChEBI:CHEBI:57589; Evidence={ECO:0000250|UniProtKB:O76082}; CC -!- CATALYTIC ACTIVITY: CC Reaction=Na(+)(out) + O-propanoyl-(R)-carnitine(out) = Na(+)(in) + O- CC propanoyl-(R)-carnitine(in); Xref=Rhea:RHEA:72103, ChEBI:CHEBI:29101, CC ChEBI:CHEBI:53210; Evidence={ECO:0000250|UniProtKB:O76082}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(S)-carnitine(out) + Na(+)(out) = (S)-carnitine(in) + CC Na(+)(in); Xref=Rhea:RHEA:72095, ChEBI:CHEBI:11060, CC ChEBI:CHEBI:29101; Evidence={ECO:0000250|UniProtKB:O76082}; CC -!- CATALYTIC ACTIVITY: CC Reaction=Na(+)(out) + O-acyl-(R)-carnitine(out) = Na(+)(in) + O-acyl- CC (R)-carnitine(in); Xref=Rhea:RHEA:72107, ChEBI:CHEBI:29101, CC ChEBI:CHEBI:75659; Evidence={ECO:0000250|UniProtKB:O76082}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine(out) + CC Na(+)(out) = L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine(in) CC + Na(+)(in); Xref=Rhea:RHEA:72111, ChEBI:CHEBI:29101, CC ChEBI:CHEBI:191852; Evidence={ECO:0000250|UniProtKB:O76082}; CC -!- CATALYTIC ACTIVITY: CC Reaction=N,N-dimethylglycine(out) + Na(+)(out) = N,N- CC dimethylglycine(in) + Na(+)(in); Xref=Rhea:RHEA:76591, CC ChEBI:CHEBI:29101, ChEBI:CHEBI:58251; CC Evidence={ECO:0000250|UniProtKB:O76082}; CC -!- ACTIVITY REGULATION: Inhibited by emetine, quinidine and verapamil. The CC IC(50) of emetine is 4.2 uM. Not inhibited by valproic acid. Transport CC of (R)-carnitine is stimulated by cholesterol in the plasma membrane. CC {ECO:0000250|UniProtKB:O76082}. CC -!- SUBUNIT: Interacts with PDZK1. {ECO:0000269|PubMed:15523054}. CC -!- SUBCELLULAR LOCATION: Apical cell membrane CC {ECO:0000269|PubMed:15523054, ECO:0000269|PubMed:20722056}; Multi-pass CC membrane protein {ECO:0000269|PubMed:15523054}. Basal cell membrane CC {ECO:0000250|UniProtKB:O76082}; Multi-pass membrane protein CC {ECO:0000255}. Cell membrane {ECO:0000250|UniProtKB:O76082}; Multi-pass CC membrane protein {ECO:0000250|UniProtKB:O76082}. Note=Colocalizes with CC PDZK1 on apical membranes of kidney proximal tubules (PubMed:15523054). CC In intestinal cells, apical expression is induced by TNF CC (PubMed:20722056). {ECO:0000269|PubMed:15523054, CC ECO:0000269|PubMed:20722056}. CC -!- TISSUE SPECIFICITY: Widely expressed. Expressed in kidney, liver and CC testis (PubMed:11010964). Expressed at the brush border of the small, CC large intestine and colon (at protein level) (PubMed:11010964, CC PubMed:20722056). {ECO:0000269|PubMed:11010964, CC ECO:0000269|PubMed:20722056}. CC -!- INDUCTION: Intestinal expression is induced by IFNG. CC {ECO:0000269|PubMed:20722056}. CC -!- DISEASE: Note=Defects in Slc22a5 are the cause of the juvenile visceral CC steatosis (JVS) phenotype. JVS is an autosomal recessive animal model CC of systemic carnitine deficiency. CC -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1) superfamily. CC Organic cation transporter (TC 2.A.1.19) family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB015800; BAA36590.1; -; mRNA. DR EMBL; AF111425; AAC99787.1; -; mRNA. DR EMBL; AF110417; AAD54060.1; -; mRNA. DR EMBL; BC031118; AAH31118.1; -; mRNA. DR CCDS; CCDS24687.1; -. DR RefSeq; NP_035526.1; NM_011396.3. DR AlphaFoldDB; Q9Z0E8; -. DR SMR; Q9Z0E8; -. DR STRING; 10090.ENSMUSP00000019044; -. DR ChEMBL; CHEMBL2073665; -. DR GlyConnect; 2733; 2 N-Linked glycans (1 site). DR GlyCosmos; Q9Z0E8; 3 sites, 2 glycans. DR GlyGen; Q9Z0E8; 3 sites, 2 N-linked glycans (1 site). DR iPTMnet; Q9Z0E8; -. DR PhosphoSitePlus; Q9Z0E8; -. DR jPOST; Q9Z0E8; -. DR MaxQB; Q9Z0E8; -. DR PaxDb; 10090-ENSMUSP00000019044; -. DR ProteomicsDB; 260885; -. DR DNASU; 20520; -. DR Ensembl; ENSMUST00000019044.8; ENSMUSP00000019044.8; ENSMUSG00000018900.8. DR GeneID; 20520; -. DR KEGG; mmu:20520; -. DR UCSC; uc007ixc.2; mouse. DR AGR; MGI:1329012; -. DR CTD; 6584; -. DR MGI; MGI:1329012; Slc22a5. DR VEuPathDB; HostDB:ENSMUSG00000018900; -. DR eggNOG; KOG0255; Eukaryota. DR GeneTree; ENSGT00940000154155; -. DR HOGENOM; CLU_001265_33_4_1; -. DR InParanoid; Q9Z0E8; -. DR OMA; WRLVFVW; -. DR OrthoDB; 1448128at2759; -. DR PhylomeDB; Q9Z0E8; -. DR TreeFam; TF315847; -. DR Reactome; R-MMU-200425; Carnitine metabolism. DR Reactome; R-MMU-549127; Organic cation transport. DR BioGRID-ORCS; 20520; 3 hits in 80 CRISPR screens. DR ChiTaRS; Slc22a5; mouse. DR PRO; PR:Q9Z0E8; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; Q9Z0E8; Protein. DR Bgee; ENSMUSG00000018900; Expressed in right kidney and 128 other cell types or tissues. DR ExpressionAtlas; Q9Z0E8; baseline and differential. DR GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB. DR GO; GO:0009925; C:basal plasma membrane; ISS:UniProtKB. DR GO; GO:0016323; C:basolateral plasma membrane; ISO:MGI. DR GO; GO:0031526; C:brush border membrane; IDA:BHF-UCL. DR GO; GO:0005737; C:cytoplasm; ISO:MGI. DR GO; GO:0005829; C:cytosol; ISO:MGI. DR GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI. DR GO; GO:0016020; C:membrane; IC:MGI. DR GO; GO:0005886; C:plasma membrane; ISO:MGI. DR GO; GO:1901235; F:(R)-carnitine transmembrane transporter activity; IDA:UniProtKB. DR GO; GO:0015199; F:amino-acid betaine transmembrane transporter activity; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0015226; F:carnitine transmembrane transporter activity; IDA:UniProtKB. DR GO; GO:0030165; F:PDZ domain binding; ISO:MGI. DR GO; GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IDA:MGI. DR GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW. DR GO; GO:1902270; P:(R)-carnitine transmembrane transport; IDA:UniProtKB. DR GO; GO:1900749; P:(R)-carnitine transport; IDA:UniProtKB. DR GO; GO:0007512; P:adult heart development; IMP:MGI. DR GO; GO:0009437; P:carnitine metabolic process; IMP:MGI. DR GO; GO:0015879; P:carnitine transport; IDA:MGI. DR GO; GO:0051649; P:establishment of localization in cell; IMP:MGI. DR GO; GO:0007626; P:locomotory behavior; IMP:MGI. DR GO; GO:0007005; P:mitochondrion organization; IMP:MGI. DR GO; GO:0060731; P:positive regulation of intestinal epithelial structure maintenance; ISO:MGI. DR GO; GO:0015697; P:quaternary ammonium group transport; IDA:MGI. DR GO; GO:0048608; P:reproductive structure development; IMP:MGI. DR GO; GO:0009609; P:response to symbiotic bacterium; ISO:MGI. DR GO; GO:0034612; P:response to tumor necrosis factor; IDA:UniProtKB. DR GO; GO:0034341; P:response to type II interferon; IDA:UniProtKB. DR GO; GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW. DR GO; GO:0070715; P:sodium-dependent organic cation transport; ISO:MGI. DR GO; GO:0150104; P:transport across blood-brain barrier; IMP:ARUK-UCL. DR CDD; cd17376; MFS_SLC22A4_5_OCTN1_2; 1. DR Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1. DR InterPro; IPR020846; MFS_dom. DR InterPro; IPR005828; MFS_sugar_transport-like. DR InterPro; IPR036259; MFS_trans_sf. DR InterPro; IPR004749; Orgcat_transp/SVOP. DR InterPro; IPR045915; S22A4/5. DR InterPro; IPR005829; Sugar_transporter_CS. DR NCBIfam; TIGR00898; 2A0119; 1. DR PANTHER; PTHR24064; SOLUTE CARRIER FAMILY 22 MEMBER; 1. DR PANTHER; PTHR24064:SF283; SOLUTE CARRIER FAMILY 22 MEMBER 5; 1. DR Pfam; PF00083; Sugar_tr; 1. DR SUPFAM; SSF103473; MFS general substrate transporter; 1. DR PROSITE; PS50850; MFS; 1. DR PROSITE; PS00216; SUGAR_TRANSPORT_1; 1. DR Genevisible; Q9Z0E8; MM. PE 1: Evidence at protein level; KW ATP-binding; Cell membrane; Disease variant; Glycoprotein; Ion transport; KW Membrane; Nucleotide-binding; Phosphoprotein; Reference proteome; Sodium; KW Sodium transport; Symport; Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..557 FT /note="Organic cation/carnitine transporter 2" FT /id="PRO_0000220501" FT TOPO_DOM 1..20 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 21..41 FT /note="Helical; Name=1" FT /evidence="ECO:0000255" FT TOPO_DOM 42..142 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 143..163 FT /note="Helical; Name=2" FT /evidence="ECO:0000255" FT TOPO_DOM 164..172 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 173..193 FT /note="Helical; Name=3" FT /evidence="ECO:0000255" FT TOPO_DOM 194..197 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 198..218 FT /note="Helical; Name=4" FT /evidence="ECO:0000255" FT TOPO_DOM 219..232 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 233..253 FT /note="Helical; Name=5" FT /evidence="ECO:0000255" FT TOPO_DOM 254..257 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 258..278 FT /note="Helical; Name=6" FT /evidence="ECO:0000255" FT TOPO_DOM 279..341 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 342..362 FT /note="Helical; Name=7" FT /evidence="ECO:0000255" FT TOPO_DOM 363..373 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 374..394 FT /note="Helical; Name=8" FT /evidence="ECO:0000255" FT TOPO_DOM 395..406 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 407..427 FT /note="Helical; Name=9" FT /evidence="ECO:0000255" FT TOPO_DOM 428..430 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 431..451 FT /note="Helical; Name=10" FT /evidence="ECO:0000255" FT TOPO_DOM 452..462 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 463..483 FT /note="Helical; Name=11" FT /evidence="ECO:0000255" FT TOPO_DOM 484..488 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 489..509 FT /note="Helical; Name=12" FT /evidence="ECO:0000255" FT TOPO_DOM 510..557 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT BINDING 218..225 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255" FT MOD_RES 486 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:O76082" FT MOD_RES 548 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 550 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:19144319" FT CARBOHYD 57 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 64 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 91 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VARIANT 352 FT /note="L -> R (in JVS)" FT /evidence="ECO:0000269|PubMed:9837751" SQ SEQUENCE 557 AA; 62780 MW; 6093F0EE9612B204 CRC64; MRDYDEVTAF LGEWGPFQRL IFFLLSASII PNGFNGMSIV FLAGTPEHRC LVPHTVNLSS AWRNHSIPLE TKDGRQVPQK CRRYRLATIA NFSELGLEPG RDVDLEQLEQ ESCLDGWEYD KDVFLSTIVT EWDLVCKDDW KAPLTTSLFF VGVLMGSFIS GQLSDRFGRK NVLFLTMGMQ TGFSFLQVFS VNFEMFTVLF VLVGMGQISN YVAAFVLGTE ILSKSIRIIF ATLGVCIFYA FGFMVLPLFA YFIRDWRMLL LALTVPGVLC GALWWFIPES PRWLISQGRI KEAEVIIRKA AKINGIVAPS TIFDPSELQD LNSTKPQLHH IYDLIRTRNI RVITIMSIIL WLTISVGYFG LSLDTPNLHG DIYVNCFLLA AVEVPAYVLA WLLLQYLPRR YSISAALFLG GSVLLFMQLV PSELFYLSTA LVMVGKFGIT SAYSMVYVYT AELYPTVVRN MGVGVSSTAS RLGSILSPYF VYLGAYDRFL PYILMGSLTI LTAILTLFFP ESFGVPLPDT IDQMLRVKGI KQWQIQSQTR MQKDGEESPT VLKSTAF //